ADC Therapeutics SA
NYSE:ADCT
Net Margin
ADC Therapeutics SA
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
Net Margin Comparison
ADC Therapeutics SA Competitors
| Country | CH |
| Market Cap | 385.1m USD |
| Net Margin |
-345%
|
| Country | US |
| Market Cap | 300.4B USD |
| Net Margin |
9%
|
| Country | US |
| Market Cap | 146.5B USD |
| Net Margin |
24%
|
| Country | US |
| Market Cap | 104.4B USD |
| Net Margin |
37%
|
| Country | US |
| Market Cap | 98.9B USD |
| Net Margin |
30%
|
| Country | AU |
| Market Cap | 133.1B AUD |
| Net Margin |
17%
|
| Country | US |
| Market Cap | 83.8B USD |
| Net Margin |
21%
|
| Country | US |
| Market Cap | 43.1B USD |
| Net Margin |
-33%
|
| Country | US |
| Market Cap | 40.9B USD |
| Net Margin |
-69%
|
| Country | US |
| Market Cap | 28.1B USD |
| Net Margin |
12%
|
| Country | KR |
| Market Cap | 37.2T KRW |
| Net Margin |
25%
|
Profitability Report
View the profitability report to see the full profitability analysis for ADC Therapeutics SA.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on ADC Therapeutics SA's most recent financial statements, the company has Net Margin of -345.1%.
You don't have any saved screeners yet
